Adam Wufsus/LinkedIn
Oct 3, 2026, 07:20
Adam Wufsus: Novo Nordisk Seeks Medical Liaison for Sickle Cell Disease
Adam Wufsus, Director, Medical Affairs – Rare Blood Disorders at Novo Nordisk, shared a post on Linkedin:
“I’m pleased to share that I am hiring for an exciting opportunity at Novo Nordisk for a Medical Liaison passionate about advancing care for people living with sickle cell disease (SCD).
If you have a strong interest in SCD, a passion for medical affairs, and are looking to make a meaningful impact, I encourage you to explore this opportunity.”
Stay updated with Hemostasis Today.
-
Oct 3, 2026, 08:05Are Circadian Rhythms Fueling Thrombotic Risk in Space? – RPTH Journal
-
Oct 3, 2026, 07:43Janez Urevc: Modeling Compression Ultrasound for Internal Jugular Vein Thrombosis in Astronauts
-
Oct 3, 2026, 07:16Álvaro Dubois-Silva: Rethinking the Obesity Paradox in Cancer-Associated VTE
-
Oct 3, 2026, 07:09Lori Bryngelson Taylor: Expert Consensus Guidelines Flag Hypophosphatemia Risks With Injectafer
-
Oct 3, 2026, 06:40Aayush Bist: Study Reveals Distinct Social Patterns in Anemia, Excess Adiposity, and High Blood Pressure Among Women in Nepal
-
Oct 3, 2026, 06:39Ahmed Bennis: Understanding the Diagnosis, Risk, and Management of ARN
-
Oct 3, 2026, 06:11Ana Cespedes: Maternal Anemia in Pregnancy Linked to Differences in Infant Brain Structure
-
Oct 3, 2026, 05:52Kemal Karaagac: When Vitamin K Antagonists Remain Essential in Cardiac Care
-
Oct 3, 2026, 05:32Shiavax J. Rao: PERT 2026 Session Explores Long-Term Anticoagulation and DOAC Management